Dr. Sherif Fakhry Mohamed Abdelnaby, President of the Egyptian Russian University, announced that the Faculty of Pharmacy organized a workshop titled: “The Drug Journey: From Factory to Patient”. The event was held as part of the university administration’s support for the concept of continuous pharmaceutical education and professional development, and its ongoing efforts to link academic knowledge with practical application. The workshop also aimed at preparing pharmacy graduates who can keep pace with the latest advancements in pharmacy and healthcare, and who are capable of competing in both local and international job markets. He added that the workshop was organized with the support of Dr. Mohamed Kamal El-Sayed Mostafa, Chairman of the University’s Board of Trustees.

In the same context, Dr. Mohamed Ehab Fetouh, Dean of the Faculty of Pharmacy at the Egyptian Russian University, confirmed that the workshop was organized under the supervision of Dr. Alaa Zaki, Director of the Center for Continuing Pharmacy Education and Training. He pointed out that the workshop covered all stages of the drug journey—from manufacturing to reaching the patient—including registration procedures, stability studies, product stability, and bioequivalence.

The Dean added that the workshop was held in collaboration with Pharma Guide Center and Beit Al-Khebra for Pharmaceuticals, and hosted the following speakers:

Dr. Noha Mostafa Okasha Abdallah, Business Development Manager at Pharma Guide.

Dr. Asmaa Hussein, Executive Director at Beit Al-Khebra for Pharmaceuticals.

For his part, Dr. Jamil Abdallah, Vice Dean of the Faculty of Pharmacy for Education and Student Affairs at the Egyptian Russian University, stated that the workshop was attended by more than 87 students and 11 faculty and teaching assistant members, and that all participants received certified certificates from the Faculty of Pharmacy and the collaborating companies.

He added that the workshop aimed to shed light on the drug journey starting from the research and development stage until it reaches the patient, passing through stages of registration, quality assurance, stability studies, and bioequivalence. The sessions also discussed the regulatory aspects of the pharmaceutical industry, the role of regulatory bodies, and job opportunities in regulatory affairs and the pharmaceutical manufacturing sector.